Table 1 Clinicopathological characters of the patients with conventional stent

1

BD ca (Bim)

I

26

28

moderate

Stage IVa

Stage IIIa

2

BD ca (Bm)

I

58

12

well

Stage III

Stage IIIb

3

BD ca (Bim)

I

54

43

moderate

Stage III

Stage IIIb

4

BD ca (Bmi)

I

146

70

moderate

Stage III

Stage IIIb

5

BD ca (Bim)

I

49

60

well

Stage III

Stage IIIa

6

BD ca (Bi)

I

448

10

well

Stage III

Stage IIIb

7

BD ca (Bcls)

II

DSC + RT

105

25

well

Stage II

Stage II

8

BD ca (Bi)

I

40

17

well

Stage I

Stage I

9

BD ca (Bim)

I

40

22

moderate

Stage I

Stage I

10

BD ca (Bmi)

I

10

30

poor

Stage III

Stage I

11

BD ca (Bim)

I

77

46

well

Stage II

Stage I

12

BD ca (Bsm)

I

40

35

poor

Stage III

Stage IIIb

13

BD ca (Bim)

I

28

38

well

Stage III

Stage IIIa

14

BD ca (Bim)

I

RT

28

18

adenosquamous

Stage II

Stage II

15

BD ca (Bim)

II

90

30

moderate

Stage II

Stage IIIb

16

BD ca (Bmsc)

II

DSC

126

42

well

Stage II

Stage II

17

BD ca (Bcrls)

I

DSC + RT

217

55

moderate

Stage II

Stage II

18

BD ca (Bim)

I

43

90

poor

Stage III

Stage IIIb

19

BD ca (Bim)

I

45

28

well

Stage III

Stage IIIb

20

BD ca (Bmi)

I

37

55

well

Stage III

Stage IIIb

21

GB ca (C)

II

DSC

200

30

moderate

Stage III

Stage IIIa

22

BD ca (Bi)

I

22

28

moderate

Stage III

Stage IIIa

23

BD ca (BmC)

I

45

25

well

Stage II

Stage II

24

BD ca (Bmi)

I

20

68

well

Stage III

Stage IIIa

25

BD ca (Bs)

II

DSC

116

59

well

Stage IVb

Stage IIIa

26

BD ca (BmspC)

II

DSC

128

45

well

Stage I

Stage I

27

BD ca (BpcsmiJ)

IV

DSC

143

46

well

Stage III

Stage IIIb

28

BD ca (Brplcsm)

III

DSC

135

40

well

Stage IVa

Stage IVa

29

BD ca (Brcs)

III

DSC

105

30

well

Stage III

Stage IIIb

30

BD ca (Bcsrl)

III

DSC

114

50

moderate

Stage IVb

Stage IVa

31

BD ca (Bpcrls)

III

DSC

94

76

moderate

Stage IVa

Stage IVa

32

GB ca (GfbnC)

III

DSC

151

50

well

Stage III

Stage IIIa